RF gives $6m on Tomsk's biodegradable retention suture
27 Mar '12
Tomsk State University (TSU) has won the federal grant of 180 million rubles ($6m) on the project to set up experimental production of biodegradable retention suture based on glyoxal, a recently discovered high-purity substance, news agency RIA Novosti reports citing Aleksey Knyazev, one of project coordinators.
As Marchmont wrote earlier, the TSU, in cooperation with the Siberian State Medical University (SibSMU) and Tomsk Polytechnic University (TPU), launched a project to create a technology to produce modern biodegradable surgical suture (see Tomsk Suture for Surgeons of the Future of February 17, 2012). The project is expected to result in the first Russian plant to produce dissolvable retention suture from glyoxal, a substance believed to be of superb purity and remarkably low toxicity when in contact with humans. According to Mr. Knyazev, biodegradable polymers are the most important medical glyoxal-based substances, used in production of surgical monofilament suture. Specialists believe monofilament suture to qualitatively surpass other retention materials.
TSU scientists are working on a technology of obtaining surgical monofilament retention suture from glycolic and lactic acid polymers. The project is scheduled to last two years. In addition to $6m federal funding, the university expects to raise funding from non-budgetary sources.